Blood clots in spleen were unusual first sign in case of acquired TTP
A young man with unusual blood clots in the spleen was ultimately diagnosed with immune-mediated thrombotic thrombocytopenic purpura (TTP) — also known as acquired…
News
Platelet-boosting treatment curbs bleeding for ITP patients
Oral hetrombopag safely boosts platelet counts and reduces bleeding and the need for rescue therapy in adults with persistent immune thrombocytopenia (ITP) who have…
Rare bleeding disorder meets clotting gene in unusual case
The rare coexistence of von Willebrand disease (VWD) type 3 and factor V Leiden (FVL) can put patients at risk for…
COVID-19 in Canada linked to clotting problems but not TTP
The number of cases of the blood disorder thrombotic thrombocytopenic purpura (TTP) did not increase during the pandemic, but COVID-19 was linked to more…
ITP associated with high risk of blood clots that block circulation
People with immune thrombocytopenia (ITP) are at high risk of developing blood clots that block circulation, according to an analysis that combined results of…
Heavy menstrual bleeding affects over 90% of women with VWD
Heavy menstrual bleeding (HMB) affects 93% of women with von Willebrand disease (VWD) at some point in life, according to a Swedish study that…
TTP in pregnancy boosts adverse maternal, fetal outcomes: Study
Pregnant women with thrombotic thrombocytopenic purpura (TTP) in the U.S. are nearly 20 times more likely to experience an adverse maternal outcome, according to…
Wayrilz recommended for approval in Europe to treat ITP
An arm of the European Medicines Agency (EMA) is recommending that Wayrilz (rilzabrutinib) be approved to treat adults with immune thrombocytopenia (ITP) who…
Preclinical study points to new way to treat VWD type 1
Researchers created an experimental treatment for von Willebrand disease (VWD) type 1 that aims to stabilize the protein whose defect causes the disease, increasing…
Switching to Adzynma slashes hospital stays in congenital TTP
Switching from treatment with fresh frozen plasma (FFP) to Adzynma (ADAMTS13, recombinant-krhn) can help people with congenital thrombotic thrombocytopenic purpura (TTP) avoid hospital stays,…
